Egg-allergic patients can be safely vaccinated against influenza
…, ES Chan, J Paradis, L Frenette, M Ouakki… - Journal of Allergy and …, 2012 - jacionline.org
For both cohorts, patients were examined immediately before vaccination, remained under
observation for 60 minutes postvaccination, and were then reexamined for any sign of …
observation for 60 minutes postvaccination, and were then reexamined for any sign of …
Protection against omicron (B. 1.1. 529) BA. 2 reinfection conferred by primary omicron BA. 1 or pre-omicron SARS-CoV-2 infection among health-care workers with …
Background There is a paucity of data on vaccine-induced or infection-induced (hybrid or
natural) immunity against omicron (B.1.1.529) subvariant BA.2, particularly in comparing the …
natural) immunity against omicron (B.1.1.529) subvariant BA.2, particularly in comparing the …
An outbreak of severe respiratory tract infection due to human metapneumovirus in a long-term care facility
…, C Sauvageau, M Ouakki… - Clinical Infectious …, 2007 - academic.oup.com
Background . Human metapneumovirus (hMPV) is a newly described paramyxovirus that is
mainly associated with bronchiolitis in children. We sought to describe the epidemiological, …
mainly associated with bronchiolitis in children. We sought to describe the epidemiological, …
Two-dose SARS-CoV-2 vaccine effectiveness with mixed schedules and extended dosing intervals: test-negative design studies from British Columbia and Quebec …
DM Skowronski, S Setayeshgar, Y Febriani, M Ouakki… - MedRxiv, 2021 - medrxiv.org
Background The Canadian COVID-19 immunization strategy deferred second doses and
allowed mixed schedules. We compared two-dose vaccine effectiveness (VE) by vaccine type (…
allowed mixed schedules. We compared two-dose vaccine effectiveness (VE) by vaccine type (…
Understanding vaccine hesitancy in Canada: results of a consultation study by the Canadian Immunization Research Network
E Dubé, D Gagnon, M Ouakki, JA Bettinger, M Guay… - PloS one, 2016 - journals.plos.org
“Vaccine hesitancy” is a concept now frequently used in vaccination discourse. The
increased popularity of this concept in both academic and public health circles is challenging …
increased popularity of this concept in both academic and public health circles is challenging …
Estimated protection of prior SARS-CoV-2 infection against reinfection with the Omicron variant among messenger RNA–vaccinated and nonvaccinated individuals in …
…, N Brousseau, R Gilca, M Ouakki… - JAMA network …, 2022 - jamanetwork.com
Importance The Omicron variant is phylogenetically and antigenically distinct from earlier
SARS-CoV-2 variants and the original vaccine strain. Protection conferred by prior SARS-CoV-…
SARS-CoV-2 variants and the original vaccine strain. Protection conferred by prior SARS-CoV-…
Two-dose severe acute respiratory syndrome coronavirus 2 vaccine effectiveness with mixed schedules and extended dosing intervals: test-negative design studies …
DM Skowronski, Y Febriani, M Ouakki… - Clinical Infectious …, 2022 - academic.oup.com
Background The Canadian coronavirus disease 2019 (COVID-19) immunization strategy
deferred second doses and allowed mixed schedules. We compared 2-dose vaccine …
deferred second doses and allowed mixed schedules. We compared 2-dose vaccine …
Comparison of risk factors for human metapneumovirus and respiratory syncytial virus disease severity in young children
…, J Carbonneau, M Ouakki… - The Journal of …, 2012 - academic.oup.com
Background. Human metapneumovirus (hMPV) and respiratory syncytial virus (RSV) are
leading pediatric pathogens. However, risk factors for severe hMPV disease remain unknown. …
leading pediatric pathogens. However, risk factors for severe hMPV disease remain unknown. …
Risk of narcolepsy associated with inactivated adjuvanted (AS03) A/H1N1 (2009) pandemic influenza vaccine in Quebec
J Montplaisir, D Petit, MJ Quinn, M Ouakki… - PloS one, 2014 - journals.plos.org
Context An association between an adjuvanted (AS03) A/H1N1 pandemic vaccine and
narcolepsy has been reported in Europe. Objective To assess narcolepsy risk following …
narcolepsy has been reported in Europe. Objective To assess narcolepsy risk following …
Higher risk of measles when the first dose of a 2-dose schedule of measles vaccine is given at 12–14 months versus 15 months of age
…, F Guillemette, J Soto, M Ouakki… - Clinical infectious …, 2012 - academic.oup.com
Background. In 2011, >750 cases of measles were reported in Quebec, Canada, where a
routine 2-dose measles immunization schedule, in which measles vaccine is given at 12 and …
routine 2-dose measles immunization schedule, in which measles vaccine is given at 12 and …
